

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/09/19/2745419/0/en/Annexon-Biosciences-to-Participate-in-the-2023-Cantor-Global-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/09/18/2745172/0/en/Annexon-Reports-Inducement-Grant-to-New-Employee-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2023/08/07/2719531/0/en/Annexon-Highlights-Recent-Pipeline-and-Business-Progress-and-Reports-Second-Quarter-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2023/08/02/2717317/0/en/Annexon-Reports-Inducement-Grant-to-New-Employee-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.fiercebiotech.com/biotech/annexon-finds-more-silver-linings-failed-eye-disease-trial-ahead-talks-fda
https://www.globenewswire.com/news-release/2023/07/30/2714521/0/en/Annexon-Presents-ARCHER-Trial-Results-at-ASRS-2023-Highlighting-Potential-of-ANX007-as-a-Differentiated-Treatment-for-Geographic-Atrophy.html
https://www.globenewswire.com/news-release/2023/07/27/2711977/0/en/Annexon-Biosciences-Strengthens-Leadership-Team-with-Appointment-of-Jamie-Dananberg-M-D-as-Chief-Medical-Officer.html
https://www.globenewswire.com/news-release/2023/07/24/2709360/0/en/Annexon-to-Report-ARCHER-Phase-2-Trial-Results-in-Geographic-Atrophy-at-ASRS-2023.html
https://www.fiercebiotech.com/biotech/annexons-eye-disease-med-improved-vision-phase-2-trial-flunked-primary-goal-ceo-was
https://www.clinicaltrialsarena.com/news/annexon-results-ga-therapy/